- ISIN
- US18914F1030
- Sector
- Healthcare
- Industry
- Healthcare Plans
- IPO Date
- Jan 2, 2001
Highlights
- Market Cap
- $2.68B
- Enterprise Value
- $2.51B
- EPS (TTM)
- -$0.11
- Total Revenue (TTM)
- $2.21B
- Gross Profit (TTM)
- $939.14M
- EBITDA (TTM)
- -$55.21M
- Year Range
- $1.58 - $5.22
- Target Price
- $3.33
- ROA (TTM)
- -8.16%
- ROE (TTM)
- -16.78%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
CLOV Performance Chart
Clover Health Investments, Corp. (CLOV) is up 118.7% since the beginning of the year. At $5 per share, CLOV is trading just below its 52-week high of $5. Investors who bought $1,000 worth of CLOV shares 5 years ago would now be looking at an investment worth $372.
Loading charts...
Returns By Period
Clover Health Investments, Corp. (CLOV) has returned 118.72% so far this year and 70.20% over the past 12 months.
Clover Health Investments, Corp.
- 1D
- 2.80%
- 1M
- 44.79%
- YTD
- 118.72%
- 6M
- 97.69%
- 1Y
- 70.20%
- 3Y*
- 79.65%
- 5Y*
- -17.96%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.15%
- 1Y
- 24.03%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
CLOV Monthly Returns History
Based on dividend-adjusted daily data since Jun 12, 2020, CLOV's average daily return is +0.09%, while the average monthly return is +2.24%. At this rate, an investment would double in approximately 2.6 years.
Historically, 42% of months were positive and 58% were negative. The best month was May 2024 with a return of +74.6%, while the worst month was Jul 2021 at -39.4%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 5 months.
On a daily basis, CLOV closed higher 45% of trading days. The best single day was Jun 8, 2021 with a return of +85.8%, while the worst single day was Jun 9, 2021 at -23.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -4.68% | -6.70% | -15.79% | 56.25% | 44.73% | 29.15% | 118.72% | ||||||
| 2025 | 39.37% | -9.57% | -9.57% | -5.29% | -7.65% | -11.15% | 3.58% | -9.34% | 16.79% | 15.36% | -29.46% | -5.62% | -25.40% |
| 2024 | 0.64% | -9.84% | -8.09% | -20.65% | 74.60% | 11.82% | 55.28% | 37.70% | 7.22% | 46.10% | -15.53% | -9.48% | 230.85% |
| 2023 | 43.09% | -0.75% | -35.98% | -12.60% | 14.66% | 5.93% | 39.34% | 4.80% | -17.56% | -11.73% | -3.39% | 3.38% | 2.43% |
| 2022 | -30.65% | 5.43% | 30.51% | -24.23% | -0.74% | -19.85% | 30.84% | -6.79% | -34.87% | -7.06% | -17.09% | -29.05% | -75.01% |
| 2021 | -16.82% | -32.62% | -19.57% | 30.29% | -22.44% | 74.35% | -39.41% | 6.32% | -13.87% | 1.49% | -33.87% | -25.00% | -77.82% |
Benchmark Metrics
Clover Health Investments, Corp. has an annualized alpha of -1.52%, beta of 1.47, and R2 of 0.08 versus S&P 500 Index. Calculated based on daily prices since June 12, 2020.
- This stock participated in 209.45% of S&P 500 Index downside but only 131.12% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.08 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -1.52%
- Beta
- 1.47
- R²
- 0.08
- Upside Capture
- 131.12%
- Downside Capture
- 209.45%
Return for Risk
Risk / Return Rank
CLOV ranks 69 for risk / return — better than 69% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CLOV | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.04 | ||
| Sortino ratioReturn per unit of downside risk | -1.02 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.37 | -0.15 |
| Calmar ratioReturn relative to maximum drawdown | 1.27 | 2.78 | -1.51 |
| Martin ratioReturn relative to average drawdown | 2.32 | 12.44 | -10.12 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Clover Health Investments, Corp.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Clover Health Investments, Corp. was 97.19%, occurring on Apr 17, 2024. The portfolio has not yet recovered.
The current Clover Health Investments, Corp. drawdown is 76.79%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2024 bear market2024 | -97.19%Apr 2024 | 2y 10mo | — | 5y 16dJun 2021 - now |
2021 bear market2021 | -60.05%May 2021 | 4mo 19d | 22d | 5mo 11dDec 2020 - Jun 2021 |
2020 bear market2020 | -24.35%Nov 2020 | 1mo 13d | 1mo 9d | 2mo 22dSep 2020 - Dec 2020 |
2020 pullback2020 | -7.48%Aug 2020 | 1mo 8d | 22d | 2moJul 2020 - Sep 2020 |
2020 pullback2020 | -7.25%Sep 2020 | 3d | 5d | 8dSep 2020 - Sep 2020 |
Drawdown Indicators
| CLOV | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.19% | -56.78% | -40.41% |
Max Drawdown (1Y)Largest decline over 1 year | -55.50% | -9.10% | -46.40% |
Max Drawdown (3Y)Largest decline over 3 years | -64.73% | -18.90% | -45.83% |
Max Drawdown (5Y)Largest decline over 5 years | -95.49% | -25.43% | -70.06% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -76.79% | -1.80% | -74.99% |
Average DrawdownAverage peak-to-trough decline | -76.59% | -10.71% | -65.88% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.46% | 2.03% | +28.43% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Clover Health Investments, Corp. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Clover Health Investments, Corp. is priced in the market compared to other companies in the Healthcare Plans industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CLOV relative to other companies in the Healthcare Plans industry. Currently, CLOV has a P/S ratio of 1.2. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for CLOV in comparison with other companies in the Healthcare Plans industry. Currently, CLOV has a P/B value of 7.9. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with CLOV
Add Clover Health Investments, Corp. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with CLOV